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A B S T R A C T
In humans dietary circulating nitrate accumulates rapidly in saliva through active transport in the salivary
glands. By this mechanism resulting salivary nitrate concentrations are 10–20 times higher than in plasma. In
the oral cavity nitrate is reduced by commensal bacteria to nitrite, which is subsequently swallowed and further
metabolized to nitric oxide (NO) and other bioactive nitrogen oxides in blood and tissues. This entero-salivary
circulation of nitrate is central in the various NO-like eﬀects observed after ingestion of inorganic nitrate. The
very same system has also been the focus of toxicologists studying potential carcinogenic eﬀects of nitrite-
dependent nitrosamine formation. Whether active transport of nitrate and accumulation in saliva occurs also in
rodents is not entirely clear. Here we measured salivary and plasma levels of nitrate and nitrite in humans, rats
and mice after administration of a standardized dose of nitrate.
After oral (humans) or intraperitoneal (rodents) sodium nitrate administration (0.1 mmol/kg), plasma
nitrate levels increased markedly reaching ~300 µM in all three species. In humans ingestion of nitrate was
followed by a rapid increase in salivary nitrate to > 6000 µM, ie 20 times higher than those found in plasma. In
contrast, in rats and mice salivary nitrate concentrations never exceeded the levels in plasma. Nitrite levels in
saliva and plasma followed a similar pattern, ie marked increases in humans but modest elevations in rodents.
In mice there was also no accumulation of nitrate in the salivary glands as measured directly in whole glands
obtained after acute administration of nitrate.
This study suggests that in contrast to humans, rats and mice do not actively concentrate circulating nitrate
in saliva. These apparent species diﬀerences should be taken into consideration when studying the nitrate-
nitrite-nitric oxide pathway in rodents, when calculating doses, exploring physiological, therapeutic and
toxicological eﬀects and comparing with human data.
1. Introduction
The nitrate-nitrite-NO pathway has emerged as an important
additional source of NO generation in mammals complementing the
classical NO synthase (NOS)-dependent pathway [1,2]. Inorganic
nitrate formed following endogenous oxidation of NOS-derived NO
or from exogenous dietary sources can be serially reduced to form
nitrite and subsequently NO and a variety of other potentially bioactive
nitrogen oxides. Ingestion of inorganic nitrate results in measurable
NO-like bioactivity in both humans and animals including reductions
in blood pressure [3,4], inhibition of platelet aggregation [5] as well as
improvement of metabolic functions [6,7]. The fact that nitrate and
nitrite can be substrates for generation of NO has challenged the
dogma that dietary nitrate has detrimental health eﬀects. Prior to the
discovery of the nitrate-nitrite-NO pathway, nitrate was mostly known
for being a substrate for the generation of potentially carcinogenic
nitrosamines [8]. Interestingly, the route to nitrosamine formation
from nitrate is the same as that leading to NO since both require
intermediate formation of the more reactive nitrite anion.
A central process in the bioactivation of nitrate in humans is its
active uptake from blood by the salivary glands and excretion in saliva.
In the oral cavity commensal bacteria reduce salivary nitrate to the
more reactive nitrite anion [9]. Nitrite is then swallowed and can form
a number of nitrogen oxides locally in the acidic gastric environment
and systemically in blood and tissues after absorption [1]. In humans
the degree of nitrate accumulation in saliva is remarkable and it is
believed that 25% of all circulating nitrate is taken up by the salivary
glands with resulting salivary levels that are up to 20 times higher than
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in plasma [10–12]. The requirement of salivary accumulation of nitrate
and reduction to nitrite for the nitrate-nitrite-NO pathway to operate is
clearly illustrated in experiments where the test persons either avoids
swallowing saliva during a period following nitrate ingestion [5,11] or
uses an antibacterial mouthwash to prevent bacterial nitrate reduction
[12]. In both cases the physiological eﬀects of nitrate are abolished.
While most of the favorable eﬀects of dietary nitrate observed in
humans occur also in rodents, the required doses to observe similar
eﬀects in rodents are typically considerably higher [13]. There have
been suggestions that rodents do not concentrate nitrate in saliva [14–
16] but direct measurements and comparisons with humans are
currently missing. In this study we set out to directly compare salivary
nitrate concentration in humans, rats and mice by administering a
standardized amount of sodium nitrate followed by repeated blood-
and saliva samples over time.
2. Material and methods
The human part of the study was approved by the Karolinska
Institute regional ethics committee in Stockholm, Sweden. The experi-
mental protocols were approved by Institutional Animal Care and Use
Committee (IACUC) at the Karolinska Institute in Stockholm, Sweden,
and performed according to the National Institutes of Health guide-
lines for the conduct of experiments in animals.
2.1. Study participants and experimental animals
Five healthy volunteers aged 27–57 years (3 females) participated
in the study. The subjects arrived in the lab in the morning after an
overnight fast and after having been instructed to avoid nitrate-rich
food the preceding day. A catheter was placed in the antecubital vein
for sampling. After collection of basal blood and saliva samples, sodium
nitrate (0.1 mmol/kg dissolved in 10 mL of drinking water) was
ingested and blood and saliva were collected repeatedly during 60 min.
Rats (Sprague Dawley) weighting 280–500 g were anesthetized
using Inactin (60 mg/kg) and ketamine (60 mg/kg) and tracheostomy
was carefully performed to avoid any damage to the submandibular
glands. A catheter (PE50) was inserted in the femoral vein for blood
collection. After this, a low dose of pilocarpine (64 µg/kg) was
intraperitoneally administrated to induce a low ﬂow of saliva suﬃcient
to allow for collection using a capillary tube. After baseline collection of
saliva and blood, sodium nitrate was administrated intraperitoneally
(0.1 mmol/kg) and saliva and blood were collected at 15, 30, 45 and,
60 min. In mouse experiments, animals (C57Bl/J6) were anesthetized
using ketamine (100 mg/kg) and then pilocarpine (64 µg/kg) was
administrated intraperitoneally. Saliva and blood were collected before
(baseline) and 60 min after an intraperitoneal injection of sodium
nitrate (0.1 mmol/kg). In another set of experiments, 6 mice received a
single gastric gavage of sodium nitrate (0.1 mmol/kg). After 60 min the
mice were anesthetized and blood was collected along with excision
and rapid removal of the sublingual and parotid salivary glands. No
pilocarpine was used in these experiments.
2.2. Sample preparation
Blood samples were immediately centrifuged at +4 °C (4700×g,
5 min) and plasma was stored at −80 °C until analyses. The plasma
samples were extracted using HPLC grade methanol (CROMASOLV,
Sigma-Aldrich) and the methanol was pre chilled in the freezer using a
glass bottle to avoid nitrite/nitrate contamination from diﬀerent plastic
materials. In brief, 100 µL methanol was added to 100 µL plasma in
1.5 mL Eppendorf tubes tested for nitrite/nitrate contamination. The
tubes were vortexed and then centrifuged for 10 min 4 °C 10,000g.
The saliva samples were centrifuged for 10 min at 4 °C and 10,000g
before dilution with carrier solution containing 10% HPLC grade
methanol.
The salivary glands removed from the animals were weighted, cut in
smaller pieces and immediately placed in ice-cold methanol 1 mL/g
tissue. The tissue was then homogenized using a bullet blender with
Zirccox beads. After homogenization, the samples were centrifuged for
10 min at 4 °C 10,000g. The supernatant was then transferred to
another tube and stored overnight at −20 °C.
2.3. Nitrate and nitrite assessment
A HPLC system dedicated to assessment of nitrite and nitrate
(ENO-20; EiCom, Japan) and attached to an auto-sampler (840,
EiCom, Kyoto, Japan) was used. The method is sensitive and speciﬁc
to nitrite and nitrate, and is based on the separation of nitrate by
reverse-phase/ion exchange chromatography, followed by inline re-
duction of nitrate to nitrite with cadmium and reduced copper.
Derivatization of reduced nitrate was performed with Griess reagent,
and the level of diazo compounds was measured at 540 nm. The reactor
solution was freshly prepared before analysis. A standard curve was
prepared from sodium nitrite and sodium nitrate, diluted with carrier
solution in the range of 0.1–20 µM. Aliquots of standards were stored
at −20 °C. The slope was examined and used to calculate the
concentration in the samples.
Immediately before running the samples in the HPLC, 100 µL of the
samples were transferred to a 96 well plate with conical wells (Costar,
nitrate- and nitrite-free). To avoid evaporation and also contamination
from the auto sampler that contains a lot of electrical components
releasing NO to the surrounding air, we sealed the plate with a ﬁlm that
was sterile and easy for the auto sampler needle to penetrate. The
samples were kept at 4 °C by a cooling device in the auto sampler. The
data collected and analyzed using the PowerChrom software (V 2.7.9,
eDAQ).
2.4. Drugs and solutions
All drugs and reagents used were purchased from Sigma Chemical
Co. (St Louis, MO, USA). All drugs were dissolved in saline solution
immediately before use.
2.5. Statistical analysis
The results are expressed as means ± S.E.M. The comparisons
between groups were assessed by t tests, two-way analysis of variance
using Bonferroni correction or one-way analysis of variance followed by
Dunnett's multiple comparison tests. A p-value < 0.05 was considered
signiﬁcant.
3. Results
Plasma and salivary levels of nitrate after administration of nitrate
are shown in Fig. 1. In humans, plasma and salivary nitrate increased
as expected after ingestion of sodium nitrate. At 60 min, plasma nitrate
was 299 ± 14 µM whereas the levels in saliva had reached 6022 ±
485 µM, giving a ratio saliva to plasma of around 20:1 (Fig. 1E). In rats
and mice injected intraperitoneally with nitrate, plasma nitrate also
greatly increased during the observation period. At 60 min, plasma
nitrate levels had increased to 357 ± 72 µM in rats and 261 ± 54 µM in
mice (Fig. 1C) and were similar to those found in saliva (343 ± 91 and
260 ± 29 for rats and mice, respectively, Fig. 1D). Thus, in rats and
mice, the ratio saliva:plasma for nitrate was close to 1:1 (Fig. 1E).
Representative HPLC tracings of nitrate levels in saliva samples from
the three species studied are shown in Fig. 2.
The levels of nitrite in plasma and saliva increased markedly in
humans after administration of nitrate (Table 1). This increase
occurred also in rodents but to a much lesser extent.
In whole salivary glands obtained from anesthetized mice having
received nitrate 60 min earlier, the levels of nitrate were no diﬀerent
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from those seen in plasma collected at the same time point (Fig. 3).
4. Comment
The results presented here demonstrate that rodents, in contrast to
humans, do not eﬀectively concentrate nitrate in saliva. As shown in
humans here and earlier, nitrate rapidly accumulates in saliva after
ingestion giving concentrations > 20 times higher than those in
plasma. This is apparently a very powerful system allowing much
nitrate to be reduced to nitrite by oral bacteria, eventually giving rise to
a number of potentially bioactive nitrogen oxides [17].
If mice and rats do not eﬀectively concentrate nitrate in saliva, why
then is dietary nitrate still bioactive also in these species? There are
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Fig. 1. Eﬀects of nitrate administration on levels on nitrate in plasma and saliva of humans, rats and mice. Nitrate was measured repeatedly in plasma (A)and saliva (B)of humans and
rats after administration of 0.1 mmol/kg sodium nitrate orally (humans, n=5) or intraperitoneally (rats, n=12). Comparison of nitrate levels in plasma (C) and saliva (D) and ratio
saliva:plasma (E) in rats, mice (n=6) and humans measured 60 min after administration of nitrate. # p < 0.01 and * p < 0.05. vs. baseline (0 min) within the same group by using
repeated measures ANOVA and Dunnett's multiple comparison test. Data are shown as mean ± S.E.M.
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Fig. 2. Representative HPLC tracings showing levels of nitrate measured in saliva
collected after administration of sodium nitrate 0.1 mmol/kg.
Table 1
Nitrite levels (μM) measured in saliva and plasma before and 60 min after administration
of sodium nitrate (0.1 mmol/kg).
Humans (n=5) Rats (n=12) Mice (n=6)
Saliva Basal 63 (38) 0.654 (0.12) 1.52 (0.51)
60 min 2023 (495)* 14.28 (4.18)* 5.04 (2.33)
Plasma Basal 0.220 (0.04) 0.245 (0.02) 0.265 (0.05)
60 min 0.716 (0.15)* 0.461 (0.10)* 0.337 (0.04)
Data are shown as mean ± (S.E.M.)
* p < 0.05. vs. baseline (0 min)
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several possible explanations. First, the passive diﬀusion of nitrate
from blood to saliva indicated here might be suﬃcient to enable enough
nitrite formation by oral commensal bacteria. If true this may then
explain why higher doses of nitrate are typically needed in rodent
studies to achieve a physiological NO-like eﬀect. Second, rodents may
have compensated the ineﬀective nitrate transport and subsequent oral
microbial nitrate reduction by instead upregulating mammalian sys-
tems to reduce nitrate to nitrite. Indeed, xanthine oxidase is capable of
this and is responsible for the increase in systemic nitrite seen in germ-
free mice after administration of nitrate [18,19]. Moreover, many of the
described favorable eﬀects of nitrate (in vivo) or nitrite (in vitro) are
abolished by inhibition of XOR in rodents [20–24]. Third, rodents have
been reported to secrete nitrate in the upper gastrointestinal tract [25],
which apparently does not happen in humans [12]. This nitrate could
undergo similar metabolism by bacteria residing at these locations,
thereby enhancing the bioactivation of nitrate through its initial
reduction to nitrite.
A puzzling fact is that the eﬀects of dietary nitrate in rodents seem
to be eﬀectively blocked by local use of an antibacterial mouthwash
[13,26] like they are in humans [12]. This indeed suggests that some
enterosalivary circulation of nitrate occurs also in mice and rats and
indicates that the lower salivary nitrate and nitrite levels obtained even
without active concentration might be suﬃcient to elicit eﬀects. This is
supported by a recent study in which minute amounts of nitrite
(resembling levels found in fasting humans saliva) added to drinking
water of germ-free mice resulted in a robust physiological response
manifested as an increase in gastric mucus formation [27].
The rise in salivary nitrate after administration of nitrate was
followed by an impressive increase also in salivary nitrite in humans.
This was expected from previous studies and is a consequence of an
eﬀective bacterial nitrate reductase activity [10–12]. Salivary nitrite
increased also in rodents but to a much lesser degree. There are likely
several reasons for this. First, salivary nitrate accumulation was much
lower in rodents. Secondly, nitrate was exposed to oral bacteria during
a shorter time in rodents due to the method of collection and
pharmacological stimulation of salivary ﬂow. In addition to this, the
oral microbiome in rodents may diﬀer from humans in its nitrate
reducing capacity although this was not speciﬁcally studied here.
Plasma levels of nitrite followed the same trends in the three species
studied, with greater increases seen in humans. In aggregate, it seems
as if the enterosalivary recirculation of nitrate and resulting bioactiva-
tion to form the more reactive nitrite anion is considerably more
eﬀective in humans compared to rodents.
Besides being of interest to researchers looking at beneﬁcial
cardiovascular eﬀects of dietary nitrate, this study may also be relevant
to toxicologists looking into the potential harmful eﬀects of nitrate
including the formation of nitrosamines [8,10]. Indeed, the resulting
accumulation of nitrite in saliva after a nitrate load is much greater in
humans compared to rodents and thereby also the nitrosating capacity.
There are some limitations in this study that deserves to be
mentioned. It is diﬃcult to obtain saliva from rodents and hence
salivary ﬂow was stimulated with the use of pilocarpine. In humans this
is not needed and no pilocarpine was used. One might then argue that
the pilocarpine-induced salivary ﬂow is so high that eﬀective concen-
tration of nitrate becomes impossible. While this is most certainly true
in the sense that higher ﬂow rates will lead to lower absolute nitrate
concentrations, it is still unlikely that the dilution factor would
completely mask the concentration ability in rodents. In an eﬀort to
minimize this dilution factor we used a low dose of pilocarpine, just
enough to enable collection of saliva using capillary tubes. Thus, if
active nitrate concentration had occurred in rodents the ratio saliva:-
plasma would likely not have been as low as 1:1. Indeed, in rabbits that
also concentrate nitrate in saliva [28], a high ratio saliva:plasma is
existing even though the animals were treated with a high dose of
pilocarpine. Another potential confounder is the use of anesthetics in
the rodents, which theoretically may aﬀect the function of the salivary
glands. However, in earlier studies looking at how iodine is concen-
trated in rat saliva (the mechanisms for iodine transport in the salivary
glands is the same as for nitrate) anesthesia did not inﬂuence the
capacity to concentrate the anion [15].
In conclusion: The results from the present study support the
notion that in contrast to humans and some other mammals, rats and
mice do not actively concentrate nitrate in saliva.
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